Today: 16 May 2026
Browse Category

Earnings Reports 29 January 2026

Meta stock price jumps after earnings — but $135 billion AI capex is the new battleground

Meta stock price jumps after earnings — but $135 billion AI capex is the new battleground

Meta shares surged nearly 7% in early Frankfurt trading after the company reported a 24% jump in Q4 revenue to $59.89 billion and issued a strong Q1 forecast. Meta raised its 2026 capital expenditure guidance to $115–$135 billion, citing increased investment in AI infrastructure. Operating margin fell to 41% from 48% a year earlier. Investors weighed robust ad sales against rising costs and regulatory pressures.
29 January 2026
···
Keppel share price slips as Aster SAF plant study lands; next catalyst is Feb 5 results

Keppel share price slips as Aster SAF plant study lands; next catalyst is Feb 5 results

Keppel shares fell 0.27% to S$11.02 in afternoon trading after announcing a study with Aster for an ethanol-to-jet sustainable aviation fuel facility on Jurong Island. The project targets up to 100,000 tonnes annual output but awaits regulatory approval and a final investment decision. Investors are watching for capex details and the February 5 earnings report. Keppel said the plan won’t affect earnings this year.
29 January 2026
··
OCBC stock price inches up as Citi-backed securities-lending launch keeps focus on Feb earnings

OCBC stock price inches up as Citi-backed securities-lending launch keeps focus on Feb earnings

OCBC shares rose 0.23% to S$21.34 in Singapore trading Thursday, with about 1.8 million shares changing hands. The bank launched a securities-lending program via Citi, aiming to expand to more clients by 2026. RHB raised its target price for OCBC to S$21.30, expecting single-digit earnings growth and a 60% dividend payout. OCBC will report full-year 2025 results on Feb. 25.
29 January 2026
··
Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

Thermo Fisher shares fell 2.55% to $608.02 Wednesday, their second straight decline ahead of Thursday’s Q4 earnings call. Trading volume topped 2.3 million, above average, as investors weighed Danaher’s warning on weak academic research funding. The stock now sits 5.6% below its Jan. 22 high. Life-science tools stocks broadly declined during the session.
29 January 2026
···
Elevance Health stock rebounds nearly 6% after earnings — here’s what matters before Thursday’s trade

Elevance Health stock rebounds nearly 6% after earnings — here’s what matters before Thursday’s trade

Elevance Health shares rose 5.9% to $341.85 Wednesday after plunging 14% the previous session. The insurer projected 2026 adjusted earnings of at least $25.50 per share, below analyst forecasts, and expects a small revenue decline. Fourth-quarter operating revenue rose 10% to $49.3 billion. Medicare Advantage payment changes and rising medical costs continue to drive volatility in managed-care stocks.
29 January 2026
··
Uber stock drops 1.8% — Waabi robotaxi deal and Dutch driver ruling set up earnings test

Uber stock drops 1.8% — Waabi robotaxi deal and Dutch driver ruling set up earnings test

Uber shares fell 1.8% to $79.78 Wednesday, underperforming a flat S&P 500. A Dutch court ruled Uber drivers can be classified as self-employed, reversing a 2021 decision. Uber pledged up to $250 million to Waabi, aiming to deploy at least 25,000 robotaxis on its platform. Investors weighed regulatory and automation developments ahead of Uber’s Feb. 4 earnings report.
29 January 2026
·····
IBM stock price whipsaws after earnings beat, leaving traders with one big question for Thursday

IBM stock price whipsaws after earnings beat, leaving traders with one big question for Thursday

IBM shares closed nearly flat after volatile after-hours trading Wednesday, despite beating fourth-quarter revenue and profit estimates. Red Hat growth slowed to 10% following a U.S. government shutdown. IBM reported $19.69 billion in revenue and $4.52 adjusted EPS, and forecast over 5% revenue growth for 2026. The stock last traded at $294.16, down from a $324.20 after-hours high.
29 January 2026
··
Danaher (DHR) stock slides nearly 5% after earnings beat as 2026 outlook lands “in line”

Danaher (DHR) stock slides nearly 5% after earnings beat as 2026 outlook lands “in line”

Danaher shares fell 4.8% to $224.54 after its 2026 profit outlook matched analyst expectations. The company beat fourth-quarter profit and revenue estimates, posting $6.8 billion in revenue and $2.23 per share in adjusted earnings. Trading volume more than doubled its 50-day average. Investors focused on the pace of recovery and upcoming results from rival Thermo Fisher.
29 January 2026
··
Caterpillar stock edges up ahead of earnings as AI data-center power deal puts CAT in focus

Caterpillar stock edges up ahead of earnings as AI data-center power deal puts CAT in focus

Caterpillar shares closed Wednesday up 0.7% at $643.28 after landing a 2-gigawatt data-center power contract and an analyst price target hike. The company will report fourth-quarter and full-year results before the U.S. market opens Thursday. Investors await earnings guidance as analysts expect a 9% year-over-year profit drop.
29 January 2026
····
KLA (KLAC) stock edges up ahead of earnings as chip-tool signals roll in

KLA (KLAC) stock edges up ahead of earnings as chip-tool signals roll in

KLA shares rose 0.7% to $1,627.20 Wednesday and gained another 1.4% after hours ahead of its quarterly earnings report due Thursday. Analysts expect revenue near $3.26 billion and adjusted earnings around $8.80 per share. Evercore ISI raised its price target to $1,700. KLA’s results follow upbeat forecasts from ASML and Lam Research amid strong AI-driven chip demand.
29 January 2026
··
Exxon stock price near $138 as oil rallies; traders brace for XOM earnings Friday

Exxon stock price near $138 as oil rallies; traders brace for XOM earnings Friday

Exxon Mobil shares closed up 0.5% at $137.58 as Brent and U.S. crude hit four-month highs on supply concerns and Middle East tensions. Exxon launched a commercial carbon capture project with CF Industries in Louisiana and expanded hybrid-technology ties with China’s BYD. The company reports earnings Jan. 30, with investors watching for updates on margins and capital spending.
29 January 2026
···
1 … 83 84 85 86 87 … 248

Stock Market Today

  • Boeing Shares Fall 3.7% Amid Mixed Analyst Ratings and Insider Selling
    May 15, 2026, 7:22 PM EDT. The Boeing Company (NYSE:BA) shares dropped 3.7% to $220.63 on Friday, with trading volume rising 26% above the daily average. Despite recent analyst upgrades-including ratings of 'buy' and target prices up to $295-Boeing's stock price fell below its 50- and 200-day moving averages. The aerospace giant reported better-than-expected quarterly earnings of -$0.20 per share versus estimates of -$0.68, with revenue up 14% year-over-year to $22.22 billion. Insider selling was noted as EVP Uma M. Amuluru sold 1,503 shares valued at $351,371. Boeing holds a market capitalization of $173.92 billion and a consensus analyst rating of 'Moderate Buy,' reflecting cautious optimism amid volatility.

Latest articles

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

16 May 2026
HCW Biologics shares jumped 262% to $1.22 Friday after the company posted a $3.47 million first-quarter profit, driven by a $6.5 million licensing deal with Beijing Trimmune Biotech. The company faces a possible Nasdaq delisting and will ask shareholders to approve a reverse stock split on June 15. HCW plans to report early Phase 1 data for its alopecia drug in the first half of 2026.
BofA 7-Eleven ATM Settlement Opens, Deadline June 29 for Former Clients

BofA 7-Eleven ATM Settlement Opens, Deadline June 29 for Former Clients

16 May 2026
Bank of America agreed to pay $2.25 million to settle claims it charged duplicate balance-inquiry fees at FCTI-owned ATMs in 7-Eleven stores. Former account holders must file claims by June 29; current customers will receive automatic credits if the court approves the deal. Final approval is set for Aug. 21 in San Diego federal court. The class period covers May 2018 to November 2021.
SpaceX Nasdaq Listing Draws Closer as IPO Timeline Accelerates

SpaceX Nasdaq Listing Draws Closer as IPO Timeline Accelerates

16 May 2026
SpaceX plans to list on Nasdaq as early as June 12 under the ticker SPCX, seeking to raise about $75 billion at a $1.75 trillion valuation, sources told Reuters. The company aims to publish its prospectus next week, with investor meetings set for June 4. Bloomberg reported Brookfield has already placed a $2 billion bet ahead of the IPO. SpaceX’s filing includes supervoting shares and strict limits on shareholder proposals.
Go toTop